Platinum-antibody conjugates enhance tumor immune recognition (IMAGE)
Caption
Schematic illustration of the design and mechanism of platinum(IV)-antibody conjugates (Pt-ADCs). Pt-ADCs enhance tumor MHC-I expression, promote the expansion of tumor-reactive TCR clonotypes, and synergize with anti-PD-1 immunotherapy.
Credit
©Science China Press
Usage Restrictions
Use with credit.
License
Original content